Presentation is loading. Please wait.

Presentation is loading. Please wait.

Online supplementary material. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with.

Published byMathew Kenyon Modified over 10 years ago

Similar presentations

Presentation on theme: "Online supplementary material. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with."— Presentation transcript:

1 Online supplementary material. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock. Intensive care medicine Grimaldi D 1,2,3,4 *, Louis S 2,3,4 *, Pène F 1,2,3,4, Sirgo G 2,3,4, Rousseau C 2,3,4, Claessens YE 2,3,4,5, Vimeux L 2,3,4 Cariou A 1,2, Mira JP 1,2,3,4, Hosmalin A 2,3,4, Chiche JD 1,2,3,4 § 1 Medical Intensive Care Unit, Hôpital Cochin, AP-HP, 27 rue du Faubourg Saint Jacques 75014 Paris, France. 2 Université Paris-Descartes, 22 Rue Méchain 75014 Paris, France. 3 Institut Cochin, INSERM U1016, 22 Rue Méchain 75014 Paris, France. 4 CNRS UMR 8104, 22 Rue Méchain 75014 Paris, France. 5 Emergency department, Hôpital Cochin, AP-HP, Paris, France § corresponding author: jean-daniel.chiche@cch.aphp.frjean-daniel.chiche@cch.aphp.fr, tel: 33 1 58 41 25 01, fax: 33 1 58 41 25 05,

2

3 Supplemental figures captions Fig. S1: Dot plot of gating strategy. mDCs are CD45 +, lineage -, HLA-DR & CD11c double positive cells, pDCs are CD45 +, lineage -, HLA-DR & CD123 double positive. Corresponding isotype control for CD11c and CD123 (IgG1-APC and IgG1-PE respectively) were used. Typical example of healthy control (HC, upper panel) and patients with septic shock (SS, lower panel) are shown. Expression of HLA-DR is shown as fluorescence-activated cell sorter analysis and the corresponding MFI is indicated on the graph. Fig. S2: Evolution at day 1, 3 and 7 (D1, D3 D7) of HLA-DR MFI on circulating mDCs and pDCs in patients with septic shock (grey boxes) or non-septic shock (dashed boxes). Patients with less than 50 DCs/mL could not be analysed for HLA-DR expression. HLA-DR MFI decreased significantly in both groups and both DCs types (P=0.007 & P=0.0035 for mDCs and pDCs of septic shock group, P=0.02 & P=0.01). Fig. S3: Evolution of day 1, 3 and 7 (D1, D3 D7) mDCs and pDCs counts in patients from the non-septic shock group with (dashed boxes), or without (dotted boxes) ICU-acquired infection. Fig. S4: Evolution of individual mDC (upper panels) and pDC (lower panels) counts in patients with septic shock, which have developed (left panels) or not (right panels) ICU-acquired infections (IAI). Fig. S5: Evolution of individual HLA-DR expression on mDCs (upper panels) and pDCs (lower panels) in patients with septic shock, which have developed (left panels) or not (right panels) ICU-acquired infections (IAI).

4 Fig. S1 HC IgG1-APC IgG1-PE mDC HLA DR MFI= 16.000 lin HLA DR lin- CD123-APC pDC CD11c-PE mDC CD45 SSC PBMC IgG1-APC CD123-APC pDC CD11c-PE mDC SS IgG1-PE HLA DR MFI= 12.000 mDC CD45 PBMC SSC lin lin- HLA DR

5 Fig. S2 MFI D1D7D3 pDC s 0 5000 10000 15000 20000 25000 N=35N=26N=30N=17 N=7 D1D7D3 0 10000 20000 30000 40000 mDCs N=43N=29N=36N=17N=21N=8 Septic shock group Non-septic shock group

6 Fig. S3 cells/ml 10000 14000 18000 0 2000 6000 pDCs D1D7D3 N=25N=4N=14N=3N=6N=2 15000 25000 35000 D1D7D3 0 5000 mDCs N=25N=4N=14N=3N=6N=2 Patients without IAI Patients with IAI

7 Fig. S4 mDC IAI+mDC IAI- pDC IAI+ pDC IAI- cells/ml D1D7D3 D1D7D3

8 Fig. S5 HLA-DR mDC IS+HLA-DR mDC IS- HLA-DR pDC IS+HLA-DR pDC IS- D1D7D3D1D7D3 MFI

Download ppt "Online supplementary material. Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with."

Similar presentations

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.

A. a). d). c). f). b).e). g). Figure S1. NAT2 expression in lymphocytes and monocytes from a healthy volunteer. PBMC from a healthy volunteer were simple.
Isotype control Supplementary Figure S1. Strategy for gating CD11b+CD14-CD33+CD40+ myeloid cells. Singlets were gated from live cells shown in forward.

Isotype control Supplementary Figure S1. Strategy for gating CD11b+CD14-CD33+CD40+ myeloid cells. Singlets were gated from live cells shown in forward.
Supplementary Table 1 Table S1. Population frequency of HLA -A, -B and -C alleles. Rare alleles (frequency < 0.5%) are highlighted by a grey background.

Supplementary Table 1 Table S1. Population frequency of HLA -A, -B and -C alleles. Rare alleles (frequency < 0.5%) are highlighted by a grey background.
Supplemental Fig. 1. Gating strategy to define Treg and iNKT cell subsets. (A) Representative scatter plots showing: the lymphocyte gate (R1), CD4+ cells.

Supplemental Fig. 1. Gating strategy to define Treg and iNKT cell subsets. (A) Representative scatter plots showing: the lymphocyte gate (R1), CD4+ cells.
CD44 PD-L1 FSC Human/Mouse Stromal Markers FSC DAPI FSC SSC FSC-W FSC-H SSC-W SSC-H Live cells Tumor cells CD44 - CD44 + Supplementary Figure S1. Gating.

CD44 PD-L1 FSC Human/Mouse Stromal Markers FSC DAPI FSC SSC FSC-W FSC-H SSC-W SSC-H Live cells Tumor cells CD44 - CD44 + Supplementary Figure S1. Gating.
Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.

Retrovirally Transduced CD34++ Human Cord Blood Cells Generate T Cells Expressing High Levels of the Retroviral Encoded Green Fluorescent Protein Marker.
SSC -A SLAN CD16 CD14 CD3-CD19-CD56 CD123 HLA-DR CD33

SSC -A SLAN CD16 CD14 CD3-CD19-CD56 CD123 HLA-DR CD33
Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative

Side Scatter Forward Scatter Lineage CD1c CD141 CD303 lineage negative
Transfusion thresholds for cancer patients

Transfusion thresholds for cancer patients
Figure 1. CD11b+CD33+CD14+HLA-DR−/lo myeloid-derived suppressor cell expansion by human immunodeficiency virus.

Figure 1. CD11b+CD33+CD14+HLA-DR−/lo myeloid-derived suppressor cell expansion by human immunodeficiency virus.
FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.

FREQUENCIES AND PHENOTYPIC CHANGES OF DENDRITIC CELLS DURING ACUTE DENGUE VIRAL INFECTION Lertjuthaporn S1, Khowawisetsut L2, Keawvichit R1, Thitilertdecha.
Figure e-1A.

Figure e-1A.
Supplementary Figure 1 CD45 CD14 FSC CD123 HLA-DR CD11c Lineage

Supplementary Figure 1 CD45 CD14 FSC CD123 HLA-DR CD11c Lineage
Supplementary Figure S1

Supplementary Figure S1
Dominant IL-21 expression in TFH cells correlate with B cell pathology in HIV-infected LNs. Dominant IL-21 expression in TFH cells correlate with B cell.

Dominant IL-21 expression in TFH cells correlate with B cell pathology in HIV-infected LNs. Dominant IL-21 expression in TFH cells correlate with B cell.
Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation by Ming-Tseh Lin, Li-Hui Tseng, Haydar Frangoul,

Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation by Ming-Tseh Lin, Li-Hui Tseng, Haydar Frangoul,
by Lianne van de Laar, Aniek van den Bosch, André Boonstra, Rekha S

by Lianne van de Laar, Aniek van den Bosch, André Boonstra, Rekha S
by Venetia Bigley, Laura E. Spence, and Matthew Collin

by Venetia Bigley, Laura E. Spence, and Matthew Collin
Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 

Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection 
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.

Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses by Giulia Nizzoli, Jana Krietsch, Anja Weick, Svenja.

Similar presentations

Ads by Google